Matches in Nanopublications for { ?s ?p "[In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP722626.RAhyKL9zYab4xthPhlSx31EMzBpLHlyO6sc1C29a3QIh0130_assertion description "[In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722626.RAhyKL9zYab4xthPhlSx31EMzBpLHlyO6sc1C29a3QIh0130_provenance.
- NP1237291.RA3QvfWS1Pw6S_3s-S1hmP9xW1J2kRge-5Scg12SHY5UY130_assertion description "[In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1237291.RA3QvfWS1Pw6S_3s-S1hmP9xW1J2kRge-5Scg12SHY5UY130_provenance.